Mark Alvino sold $20k of ABEO
director at ABEONA THERAPEUTICS INC.. 4,000 shares at an average of $5.10, traded Jan 21, 2025, filed Jan 21, 2025.
Score components
- +15RoleDirector
- 0Trade size$20k at market
- 0Share of holdings soldSold 5.5% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001493152-25-003052, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 21, 2025 | SOpen-market sale Common Stock | -4,000 | $5.10 | $20k | 68,334 | Jan 21, 2025 |
Related signals
Other insiders at ABEONA THERAPEUTICS INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | ABEONA THERAPEUTICS INC. | Madhav Vasanthavada Chief Commercial Officer | $25k 4,902 shares | -2% | |
| 36Weak | ABEONA THERAPEUTICS INC. | Brendan M. O'Malley SVP, Chief Legal Officer | $35k 6,727 shares | -2% | |
| 43Moderate | ABEONA THERAPEUTICS INC. | Joseph Walter Vazzano Chief Financial Officer | $47k 9,191 shares | -2% | |
| 50Moderate | ABEONA THERAPEUTICS INC. | Vishwas Seshadri Chief Executive Officer | $101k 19,608 shares | -2% | |
| 29Weak | ABEOsell ABEONA THERAPEUTICS INC. | Mark Alvino director | $88k 15,000 shares | -19% | |
| 38Weak | ABEONA THERAPEUTICS INC. | Brendan M. O'Malley SVP, General Counsel | $71k 10,470 shares | -3% | |
| 55Moderate | ABEONA THERAPEUTICS INC. | Vishwas Seshadri Chief Executive Officer | $343k 50,676 shares | -4% | |
| 47Moderate | ABEONA THERAPEUTICS INC. | Joseph Walter Vazzano Chief Financial Officer | $120k 17,795 shares | -3% | |
| 30Weak | ABEONA THERAPEUTICS INC. | Mark Alvino director | $13k 2,000 shares | -2% | |
| 21Weak | ABEOsell ABEONA THERAPEUTICS INC. | Mark Alvino director | $45k 8,000 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.